Bio-Imaging Technologies, Inc. Wins Eastern Technology Council's Enterprise Award as ''Technology Growth Company of 2004''.

NEWTOWN, Pa. -- Bio-Imaging Technologies, Inc. (NASDAQ NMS: BITI), today announced that it has won the Enterprise Award given by the Eastern Technology Council, naming Bio-Imaging Technologies "The Technology Growth Company of 2004."

The Council's Enterprise Awards is the Philadelphia region's most prestigious competitive honors for technology companies and their leaders. Finalists and winners identified by a distinguished panel of judges, are leaders and companies with vision and impact.

Mark Weinstein, president and CEO of Bio-Imaging, accepted the award on behalf of the entire company at a ceremony last night at the Pennsylvania Convention Center in Philadelphia, where Bio-Imaging and winners in six other categories were honored.

Weinstein said, "I have always believed that Bio-Imaging Technologies is a world class operation, made largely that way by our committed and talented staff. It is very gratifying to know that the outside world shares this view and respects the efforts of such a great team."

He added, "Bio-Imaging Technologies knows that business can never be a steady-state situation. Growth is needed to stay at the cutting edge of technology and ahead of the competition. I am pleased with the work we have done over the last several years in generating organic growth and profitability. In addition, we are continuing our pursuit of strategic acquisitions to expand our global capabilities.

He concluded, "I congratulated my staff earlier today, and I informed them that there is no rule that says we can't win this award again next year. I am confident that my team will be in the running in 2005."

Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its US Core Lab in Newtown, PA, its European Core Lab in Leiden, The Netherlands, and business offices in Massachusetts, the United Kingdom and Germany. Through its recently acquired CapMed division, Bio-Imaging provides the Personal HealthKey(TM) technology and the Personal Health Record (PHR) software allowing patients to better monitor and manage their health care information.

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.